Sg Americas Securities, LLC Replimune Group, Inc. Transaction History
Sg Americas Securities, LLC
- $30.5 Billion
- Q1 2025
A detailed history of Sg Americas Securities, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 14,398 shares of REPL stock, worth $130,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,398
Previous 26,291
45.24%
Holding current value
$130,445
Previous $318,000
55.97%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding REPL
# of Institutions
162Shares Held
73.8MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$100 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$99.3 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$44.4 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$42.7 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$36 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $447M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...